Brasília, inaugurated as Brazil’s capital in 1960, is a planned city distinguished by its white, modern architecture, chiefly designed by Oscar Niemeyer. Laid out in the shape of an airplane, its “fuselage” is the Monumental Axis, 2 wide avenues flanking a massive park. In the “cockpit” is Praça dos Três Poderes, named for the 3 branches of government surrounding it. ― Google

During the past decade, Universidade de Brasília conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade de Brasília" #1 collaborator was "Sinovac Life Sciences Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universidade de Brasília" are "COVID-19" (2 trials) and "Dengue" (1 trials). Many other conditions were trialed in "Universidade de Brasília" in a lesser frequency.

Most popular intervention types in "Universidade de Brasília" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adsorbed COVID-19 (inactivated) Vaccine" (1 trials) and "Dengue 1,2,3,4 (attenuated) vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidade de Brasília" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universidade de Brasília". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universidade de Brasília, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidade de Brasília, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".